Brighton Jones LLC’s AstraZeneca AZN Stock Holding History

Brighton Jones LLC’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$771K	Buy	+3,911	New	+$754K	0.02%	544
2025 Q4	–	Sell	-3,429	Closed	-$526K	–	136
2025 Q3	$526K	Buy	3,429 +28	+0.8%	+$4.24K	0.01%	609
2025 Q2	$475K	Buy	3,401 +515	+18%	+$72.2K	0.01%	558
2025 Q1	$424K	Sell	2,886 -5	-0.2%	-$723	0.01%	441
2024 Q4	$379K	Buy	2,891 +1,394	+93%	+$195K	0.01%	462
2024 Q3	$233K	Sell	1,497 -704	-32%	-$114K	0.01%	495
2024 Q2	$343K	Sell	2,201 -64	-3%	-$9.63K	0.01%	443
2024 Q1	$307K	Buy	2,265 +30	+1%	+$3.97K	0.01%	459
2023 Q4	$301K	Buy	2,235 +501	+29%	+$65.1K	0.01%	444
2023 Q3	$235K	Buy	1,734 +75	+5%	+$10.2K	0.01%	463
2023 Q2	$237K	Buy	+1,659	New	+$244K	0.01%	460

Other funds holding AZN

Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

VAM

Vanguard Asset Management London, Ec4n 8af $117B AUM

Brighton Jones LLC's AZN Position: Q1 2026 in Review

Brighton Jones LLC opened a new position in AstraZeneca (AZN) in Q1 2026: 3,911 shares worth $771K. The stake represents 0.02% of the portfolio and ranks #544 among its holdings. This is a return to the name: Brighton Jones LLC previously reported a position in AZN as recently as Q3 2025.

Brighton Jones LLC first reported a position in AZN in Q2 2023 and has held it in 11 quarters since. 1,382 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

Brighton Jones LLC held 3,911 shares of AstraZeneca worth $771K as of Q1 2026.
AstraZeneca was a new Brighton Jones LLC position in Q1 2026.
AstraZeneca made up 0.02% of Brighton Jones LLC's portfolio in Q1 2026, its #544 holding.
Brighton Jones LLC first reported a position in AstraZeneca in Q2 2023 and has held it in 11 quarters since.
1,382 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Brighton Jones LLC's 13F filing for Q1 2026, filed 28 Apr 2026.